Cargando…

A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-α and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice

We investigated the influence of recombinant human tumour necrosis factor alpha (TNF-α) and its derivatives termed muteins III, V, VI—in which the first 3 to 7 amino acids of native TNF-α have been replaced—on the survival time of mice inoculated with leukaemia L1210 or leukaemia P338. TNF-α prolong...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warzocha, K., Góra-Tybor, J., Kwinkowski, M., Szymańska, B., Robak, T.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 1994
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365583/ https://www.ncbi.nlm.nih.gov/pubmed/18475588 http://dx.doi.org/10.1155/S0962935194000578

Ejemplares similares

The influence of 2- chlorodeoxyadenosine in combination with tumour necrosis factor-α or its mutein on murine leukaemias L1210 and P388
por: Góra-Tybor, J., et al.
Publicado: (1995)

The effect of tumour necrosis factor-α (TNF-α) muteins on human neutrophils in vitro
por: Tchorzewski, H., et al.
Publicado: (1993)

Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.
por: Mathé, G., et al.
Publicado: (1969)

Characterization of a monoclonal antibody to L1210 leukaemia.
por: Testorelli, C., et al.
Publicado: (1982)

Comparison of the antileukaemic activity of 5 aza-2-deoxycytidine and arabinofuranosyl-cytosine in rats with myelocytic leukaemia.
por: Richel, D. J., et al.
Publicado: (1988)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Development of cyclosporin A mediated immunity in L1210 leukaemia.
por: Slater, L. M., et al.
Publicado: (1991)

The antileukaemic activity of 5-Aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia.
por: Richel, D. J., et al.
Publicado: (1991)

Effect of VM-26 on the haematological responses of mice to L1210 leukaemia.
por: Hacker, M., et al.
Publicado: (1980)

Influence of micrococcus, BCG and related polysaccharides on the proliferation of the L1210 leukaemia.
por: Verloes, R., et al.
Publicado: (1978)

Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells
por: Cho, Hyunsoo, et al.
Publicado: (2021)

The response of human myeloid leukaemia xenografts to human recombinant tumour necrosis factor.
por: Clutterbuck, R. D., et al.
Publicado: (1989)

Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemia.
por: Colombo, T., et al.
Publicado: (1996)

Belinostat, a potent HDACi, exerts antileukaemic effect in human acute promyelocytic leukaemia cells via chromatin remodelling
por: Valiuliene, Giedre, et al.
Publicado: (2015)

Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells.
por: Ramu, A., et al.
Publicado: (1984)

Personality traits favourable for non-adherence to treatment in patients with chronic myeloid leukaemia: role of type A and D personality
por: Rychter, Anna, et al.
Publicado: (2023)

Successful immunotherapy with micrococcus, BCG or related polysaccharides on L1210 leukaemia after BCNU chemotherapy.
por: Verloes, R., et al.
Publicado: (1981)

DNA repeat length in chromatin from murine bone marrow and L1210 leukaemia cells.
por: Dean, S. W., et al.
Publicado: (1985)

P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype.
por: Badiner, G. J., et al.
Publicado: (1990)

Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemia
por: Yu, Hanxi, et al.
Publicado: (2022)

Serotherapy of L1210 murine leukaemia--reasons for ineffectiveness of in vivo treatment by L.1 monoclonal antibody.
por: Testorelli, C., et al.
Publicado: (1983)

L-histidinol improves the selectivity and efficacy of alkylating agents and daunomycin in mice with P388 leukaemia.
por: Warrington, R. C., et al.
Publicado: (1989)

Spontaneous overexpression of the long form of the Bcl-X protein in a highly resistant P388 leukaemia.
por: Kühl, J. S., et al.
Publicado: (1997)

Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors
por: Rychter, Anna, et al.
Publicado: (2017)

Leukæmia and Pseudo-Leukæmia
Publicado: (1877)

Cytotoxic effects of tumour necrosis factor and gamma-interferon on acute myeloid leukaemia blasts.
por: Price, G., et al.
Publicado: (1987)

Thyroid Tumours,Lymphomas, Granulocytic Leukaemia
por: Duthie, M. B., et al.
Publicado: (1973)

Case of Lymphatic Leukæmia, with Tumour in the Mediastinum
por: Gowans, James
Publicado: (1876)

5-fluorouracil and 5-fluoro-2'-deoxyuridine follow different metabolic pathways in the induction of cell lethality in L1210 leukaemia.
por: Roobol, C., et al.
Publicado: (1984)

In vivo cell synchrony in the L1210 mouse leukaemia studied with 5-fluorouracil or 5-fluorouracil followed by cold thymidine infusion.
por: Camplejohn, R. S., et al.
Publicado: (1977)

Immunotherapy in leukaemia: Immunotherapy in leukaemia
por: Mu, Xingmei, et al.
Publicado: (2023)

Polyphenols as Key Players for the Antileukaemic Effects of Propolis
por: Abubakar, Murtala B., et al.
Publicado: (2014)

Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
por: Orr, R. M., et al.
Publicado: (1994)

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.
por: Duncan, R., et al.
Publicado: (1988)

Differential growth inhibition of isoquinolinesulfonamides H-8 and H-7 towards multidrug-resistant P388 murine leukaemia cells.
por: Ido, M., et al.
Publicado: (1991)

Leukaemia
por: Haworth, C.
Publicado: (1982)

Leukæmia
por: Kaupp, B. F.
Publicado: (1899)

Leukaemia
por: Vandeveer, George G.
Publicado: (1891)

Casein and Peptides Derived from Casein as Antileukaemic Agents
por: Ledesma-Martínez, Edgar, et al.
Publicado: (2019)

MuteinDB: the mutein database linking substrates, products and enzymatic reactions directly with genetic variants of enzymes
por: Braun, Andreas, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fartv3aidqlpf27cujsl8j963g